weight loss
The program connects self-pay patients with clinicians to access GLP-1s, including Wegovy, starting at $149 per month, with no subscription fee.
The acquisition of the international telehealth company will allow Hims & Hers to expand its presence in Australia, Japan, Germany, Canada and the UK.
The digital pharmacy will sell the newly FDA-approved weight-loss pill nationwide, allowing patients to pay through their insurance or in cash.
Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic disease risk and aging.
The partnership will allow employers to purchase Noom directly through the healthcare navigation company beginning in the first quarter of 2026.
The company will scale its weight loss offerings ahead of generic GLP-1s coming to the Canadian market in 2026.
The latest round brings the company's total funding to more than $50 million.
The company will use the funds to move into the female health space and increase screening and preventive care.
Dr Ben Ng, chief medical advisor of ORA Group, explains how a hybrid model ensures the highest quality of care delivery.
The company says the layoffs occurred due to the need to focus its workforce on critical areas of the business.